KORU Medical Systems, Inc.
NASDAQ:KRMDMedical - Instruments & Supplies
+$0.06 today
- Market cap
- $149.64M
- Beta
- 0.42
- P/E (TTM)
- -80.2
- EPS (TTM)
- -$0.05
Volume 0.19M
Average 0.13M
KRMD Pre-Tax Margin
Income before tax as a percentage of revenue.
KORU Medical Systems, Inc.NASDAQ: KRMD
Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026
Pre-tax margin widens to -6.9%
Pre-tax margin was -6.9% in Q1 FY2026, up 5.2 pp from a year earlier. On a trailing-twelve-month basis it was -5.2%, up 9.9 pp year over year. Over 3 fiscal years it widened by 31.9 pp.
Context
- Pre-tax margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -6.4%
- Year-over-year change
- +11.7pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -6.4% | +11.7pp |
| FY2024 | 2024-12-31 | -18.0% | +16.3pp |
| FY2023 | 2023-12-31 | -34.3% | +4.0pp |
| FY2022 | 2022-12-31 | -38.3% | -11.2pp |
| FY2021 | 2021-12-31 | -27.1% | — |
Pre-Tax Margin vs competitors
How KRMD compares with its peers on the latest reported figures
- KRMD's LTM Mar 2026 pre-tax margin of -5.2% is the 3rd highest of the 10 companies compared; the peer median is -64.5%.
- Its year-over-year change of +9.9 pp is the 6th highest of 10, against a peer median of +23.8 pp.
- Over three fiscal years its change of +31.9 pp compares with a peer median of +30.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 35.8% | -4.6 pp | -2.9 pp | |
| LTM Mar 2026 | 8.3% | +3.5 pp | +7.3 pp | |
| LTM Mar 2026 | -5.2% | +9.9 pp | +31.9 pp | |
| LTM Mar 2026 | -24.6% | +29.8 pp | +30.9 pp | |
| LTM Mar 2026 | -60.8% | +23.8 pp | +293.7 pp | |
| LTM Mar 2026 | -64.5% | +78.3 pp | +1676.2 pp | |
| LTM Mar 2026 | -64.8% | -45.9 pp | -54.1 pp | |
| LTM Mar 2026 | -121.2% | -10.2 pp | -81.9 pp | |
| LTM Mar 2026 | -206.5% | +64.8 pp | +161.9 pp | |
| LTM Mar 2026 | -519.6% | +1013.3 pp | +85.6 pp | |
| Peer median (excluding KRMD) | -64.5% | +23.8 pp | +30.9 pp | |
Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 23.49M | 27.9M | 28.52M | 33.65M | 41.13M |
| Cost of Revenue | 9.72M | 12.53M | 11.81M | 12.31M | 15.52M |
| Gross Profit | 13.77M | 15.37M | 16.71M | 21.33M | 25.6M |
| Gross Margin | 58.6% | 55.1% | 58.6% | 63.4% | 62.3% |
| Research & Development | 2.47M | 4.96M | 5.74M | 5.26M | 4.39M |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 23.38M |
| Operating Expenses | 20.8M | 26.15M | 26.98M | 27.78M | 28.58M |
| Depreciation & Amortization | 463.13K | 587.14K | 870.39K | 772.89K | 810.5K |
| EBITDA | (5.9M) | (10.09M) | (8.9M) | (5.29M) | (1.81M) |
| EBITDA Margin | -25.1% | -36.2% | -31.2% | -15.7% | -4.4% |
| Operating Income | (7.03M) | (10.78M) | (10.27M) | (6.45M) | (2.97M) |
| Operating Margin | -29.9% | -38.6% | -36.0% | -19.2% | -7.2% |
| Interest Income | 13.08K | 145.59K | 561.33K | 444.64K | 293.4K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 665.09K | 105.71K | 496.4K | 382.49K | 356.41K |
| Income Before Tax | (6.36M) | (10.68M) | (9.77M) | (6.06M) | (2.62M) |
| Pre-Tax Margin | -27.1% | -38.3% | -34.3% | -18.0% | -6.4% |
| Income Tax Expense | (1.8M) | (2.01M) | 3.97M | 2.89K | 21.89K |
| Net Income | (4.56M) | (8.66M) | (13.74M) | (6.07M) | (2.64M) |
| Net Margin | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% |
| EPS (Basic) | (0.10) | (0.19) | (0.30) | (0.13) | (0.06) |
| EPS (Diluted) | (0.10) | (0.19) | (0.30) | (0.13) | (0.06) |
| Weighted Avg Shares | 44.39M | 45M | 45.6M | 45.8M | 46.19M |
| Weighted Avg Shares (Diluted) | 44.39M | 45M | 45.6M | 45.8M | 46.19M |
KORU Medical Systems, Inc.
NASDAQ:KRMD
Intrinsic Alpha fair value
Locked
Current Price
$3.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.